Junto Capital Management LP Has $38.47 Million Position in Encompass Health Co. (NYSE:EHC)

Junto Capital Management LP lessened its stake in shares of Encompass Health Co. (NYSE:EHC) by 56.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 416,602 shares of the company’s stock after selling 531,841 shares during the quarter. Junto Capital Management LP owned about 0.41% of Encompass Health worth $38,473,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of EHC. Vanguard Group Inc. boosted its holdings in shares of Encompass Health by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock worth $960,817,000 after acquiring an additional 138,196 shares during the period. Invesco Ltd. lifted its holdings in Encompass Health by 3.3% during the 4th quarter. Invesco Ltd. now owns 5,536,251 shares of the company’s stock worth $511,273,000 after purchasing an additional 176,135 shares during the last quarter. Alliancebernstein L.P. boosted its stake in Encompass Health by 6.0% in the 4th quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock valued at $191,799,000 after purchasing an additional 117,617 shares during the period. FMR LLC grew its holdings in Encompass Health by 0.8% in the 4th quarter. FMR LLC now owns 1,973,846 shares of the company’s stock valued at $182,285,000 after buying an additional 15,831 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Encompass Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock worth $155,176,000 after buying an additional 6,164 shares during the period. Institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of EHC stock opened at $116.45 on Friday. The business has a fifty day simple moving average of $103.44 and a 200 day simple moving average of $99.96. The company has a market cap of $11.74 billion, a P/E ratio of 26.11, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a twelve month low of $82.74 and a twelve month high of $118.27.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The firm’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same period last year, the company posted $1.12 EPS. On average, sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.58%. The ex-dividend date is Tuesday, July 1st. Encompass Health’s payout ratio is 14.05%.

Insider Activity at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the sale, the executive vice president now directly owns 79,710 shares of the company’s stock, valued at approximately $9,149,910.90. This trade represents a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the company’s stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the transaction, the insider now directly owns 11,958 shares of the company’s stock, valued at $1,394,422.38. This represents a 26.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 19,321 shares of company stock valued at $2,142,452 in the last 90 days. 2.00% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Royal Bank of Canada upped their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an “outperform” rating in a research note on Monday, April 28th. Barclays increased their target price on shares of Encompass Health from $118.00 to $129.00 and gave the stock an “overweight” rating in a research report on Friday, April 25th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Truist Financial reissued a “buy” rating and set a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Finally, UBS Group lifted their price objective on Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a report on Monday, April 28th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus price target of $120.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.